Skip to main content

Essential Medicines, Access to

  • Reference work entry
Encyclopedia of Global Justice
  • 117 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 679.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barry C, Pogge T (eds) (2005) Global institutions and responsibilities: achieving global justice. Blackwell, Oxford

    Google Scholar 

  • Banerjee A, Hollis A, Pogge T (2010) The health impact fund: incentives for improving access to medicines. Lancet 375:166–169

    Article  Google Scholar 

  • Fayerman JJ (2004) The spirit of TRIPS and the importation of medicines made under compulsory license after the August 2003 TRIPS council Agreement, 25 NW. J Int Law Bus 257:264

    Google Scholar 

  • Gupta V (2005) A mathematical approach to benefit-detriment analysis as a solution to compulsory licensing of pharmaceuticals under the TRIPS agreement, 13 Cardozo. J Int Comp Law 631:659

    Google Scholar 

  • Hollis A, Ibbott P (2006) How parallel trade affects drug policies and prices in Canada and the United States. Am J Law Med 32:193–217

    Google Scholar 

  • Mack E, Schramm M, Klasen S, Pogge T (eds) (2009) Absolute poverty and global justice: empirical data – moral theories – realizations. Ashgate, London

    Google Scholar 

  • Outterson K (2006) Patent buy-outs for global disease innovations for law- and middle-income countries. Am J Law Med 32:159

    Google Scholar 

  • Outterson K (2005) Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets. Yale J Health Policy Law Ethics 5:193–291

    Google Scholar 

  • Pogge T, Rimmer M, Rubenstein K (eds) (2010) Incentives for global public health: patent law and access to essential medicines. Cambridge University Press, Cambridge

    Google Scholar 

  • Ragavan S (2006) The first ten years of the TRIPS agreement: of the inequals of the Uruguay round. 10 Marq Intell Prop Law Rev 273:278

    Google Scholar 

  • Selgelid M, Pogge T (2010) Health rights. Ashgate, Farnham/Burlington

    Google Scholar 

  • Singer P (2008) Tuberculosis or hair loss? The Guardian [Internet]. Available from: http://www.guardian.co.uk/commentisfree/2008/sep/16/health.pharmaceuticals

  • Stiglitz J (2006) Scrooge and intellectual property rights. BMJ 333(7582):1279–1280

    Article  Google Scholar 

  • World Health Organization (2009) State of the world’s vaccines and immunization. WHO, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this entry

Cite this entry

George, A.E. (2011). Essential Medicines, Access to. In: Chatterjee, D.K. (eds) Encyclopedia of Global Justice. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9160-5_681

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-9160-5_681

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-9159-9

  • Online ISBN: 978-1-4020-9160-5

  • eBook Packages: Humanities, Social Sciences and Law

Publish with us

Policies and ethics